Literature DB >> 25072070

Long-term results of canal wall reconstruction tympanomastoidectomy.

Paul C Walker, Sarah E Mowry, Marlan R Hansen, Bruce J Gantz.   

Abstract

OBJECTIVES: This study was designed to evaluate the long-term results using the technique of canal wall reconstruction (CWR) tympanomastoidectomy with mastoid obliteration in the treatment of chronic otitis media with cholesteatoma. STUDY
DESIGN: Institutional review board-approved retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Retrospective review was performed on consecutive patients undergoing CWR tympanomastoidectomy with mastoid obliteration at a single institution from 1997 to 2011. MAIN OUTCOME MEASURES: Status of tympanic membrane and ear canal anatomy, preoperative and postoperative audiometry,residual cholesteatoma at second look surgery, postoperative complications, recurrence rate, and location.
RESULTS: Two hundred eighty-five ears in 273 patients underwent CWR tympanomastoidectomy with a mean age of 35 years with average follow-up of 4.29 years (median, 3.16 yr).A second-look ossiculoplasty was performed in 253 (89%). Recurrent retraction pocket formation occurred in 34 ears (13%). A secondary endaural atticotomy only was required to improve access for debridement in 16 of these 34 ears (5.8% of total ears).Only 7 ears (2.6%) required a revision open cavity mastoidectomy(n = 5) or subtotal petrosectomy (n = 2) for recurrent cholesteatoma. Those undergoing second-look ossiculoplasty demonstrated a small improvement in preoperative versus postoperative air-bone gap (ABG), 28 dB versus 23 dB, respectively.Postoperative infection occurred in 16 patients(5.6%) with 1 patient requiring conversion to open cavity mastoidectomy.
CONCLUSION: A CWR tympanomastoidectomy provides excellent intraoperative exposure of the middle ear and mastoid without the long-term disadvantages of a canal wall down mastoidectomy. Long-term follow-up demonstrates that there were only 2.6% failures requiring conversion to an open cavity or subtotal petrosectomy.

Entities:  

Mesh:

Year:  2014        PMID: 25072070

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

2.  Outcomes of a novel alloplastic technique for external auditory canal repair in tympanomastoidectomy.

Authors:  Karissa L LeClair; Sarah Y Bessen; Christiaan A Rees; James E Saunders
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-08-04

3.  A Prospective Study on Changes in Auricular Protrusion after Chronic Otitis Media Surgery with the Postauricular Approach.

Authors:  Yee-Hyuk Kim
Journal:  J Int Adv Otol       Date:  2020-08       Impact factor: 1.017

Review 4.  Mastoid Obliteration with Autologous Bone in Mastoidectomy Canal Wall Down Surgery: a Literature Overview.

Authors:  Ricardo Dourado Alves; Francisco Cabral Junior; Anna Carolina de Oliveira Fonseca; Ricardo Ferreira Bento
Journal:  Int Arch Otorhinolaryngol       Date:  2015-08-24

5.  Outpatient management of cholesteatoma with canal wall reconstruction tympanomastoidectomy.

Authors:  Richard Kao; Todd Wannemuehler; Charles W Yates; Rick F Nelson
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-31

6.  Postoperative surgical site infection in cholesteatoma surgery with and without mastoid obliteration, what can we learn?

Authors:  F L J Cals; H F E van der Toom; R M Metselaar; A van Linge; M P van der Schroeff; R J Pauw
Journal:  J Otol       Date:  2021-10-29

7.  Characteristics of 419 patients with acquired middle ear cholesteatoma.

Authors:  Letícia Petersen Schmidt Rosito; Maurício Noschang Lopes da Silva; Fábio André Selaimen; Yuri Petermann Jung; Marcos Guilherme Tibes Pauletti; Larissa Petermann Jung; Luiza Alexi Freitas; Sady Selaimen da Costa
Journal:  Braz J Otorhinolaryngol       Date:  2016-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.